BlackRock, Inc. 13D and 13G filings for DexCom, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-06 4:32 pm Purchase |
2024-11-30 | 13G | DexCom, Inc. DXCM |
BlackRock Inc. BLK |
40,451,057 10.400% |
7,599,584 (+23.13%) |
Filing |
| 2024-01-25 1:48 pm Sale |
2023-12-31 | 13G | DexCom, Inc. DXCM |
BlackRock Inc. BLK |
32,851,473 8.500% |
-684,207 (-2.04%) |
Filing |
| 2023-02-10 4:22 pm Sale |
2022-12-31 | 13G | DexCom, Inc. DXCM |
BlackRock Inc. BLK |
33,535,680 8.700% |
-347,000 (-1.02%) |
Filing |
| 2023-01-27 2:36 pm Unchanged |
2022-12-31 | 13G | DexCom, Inc. DXCM |
BlackRock Inc. BLK |
33,882,680 8.700% |
0 (Unchanged) |
Filing |
| 2023-01-25 10:36 am Purchase |
2022-12-31 | 13G | DexCom, Inc. DXCM |
BlackRock Inc. BLK |
33,882,680 8.800% |
1,368,864 (+4.21%) |
Filing |
| 2022-02-08 5:12 pm Purchase |
2021-12-31 | 13G | DexCom, Inc. DXCM |
BlackRock Inc. BLK |
32,513,816 8.400% |
4,480,524 (+15.98%) |
Filing |
| 2021-02-05 07:51 am Purchase |
2020-12-31 | 13G | DexCom, Inc. DXCM |
BlackRock Inc. BLK |
28,033,292 7.300% |
6,040,672 (+27.47%) |
Filing |